首页|单细胞转录组测序在多发性骨髓瘤诊治和预后中的意义

单细胞转录组测序在多发性骨髓瘤诊治和预后中的意义

扫码查看
多发性骨髓瘤(multiple myeloma,MM)是一种在临床和生物学都具有异质性的浆细胞恶性肿瘤.尽管进行了广泛的研究,在治疗方面取得了相当大的进展,但疾病的异质性和复发仍然是MM治疗的一大挑战.基于新一代测序的单细胞转录组测序(single-cell transcriptome sequencing,scRNA-seq)技术,能够从单细胞水平探测肿瘤细胞和骨髓微环境的异质性,从而提高我们对MM诊断分层、精确治疗和预后预测的认识.本文就scRNA-seq在MM诊断、治疗及预后中的应用进行综述.
Significance of single-cell transcriptome sequencing in diagnosis,treat-ment and prognosis of multiple myeloma
Multiple myeloma(MM)is a plasma cell malignancy that is heterogeneous in both clinical and bio-logical settings.Despite extensive research and considerable progress in treatment,disease heterogeneity and relapse re-main a major challenge in MM treatment.Single-cell transcriptome sequencing(scRNA-seq)technology based on next-generation sequencing can detect the heterogeneity of tumor cells and bone marrow microenvironment at the single-cell level,thereby improving our understanding of MM diagnosis stratification,precise treatment and prognosis prediction.This article reviews the application of scRNA-seq in the diagnosis,treatment and prognosis of MM.

single cell transcriptome sequencingmultiple myelomaheterogeneitymicroenvironment

刘文慧、吴涛

展开 >

甘肃中医药大学第一临床医学院,甘肃 兰州 730030

中国人民解放军联勤保障部队第九四〇医院血液科,甘肃 兰州 730050

单细胞转录组测序 多发性骨髓瘤 异质性 微环境

甘肃省创新基地和人才计划(甘肃省白血病临床医学研究中心)项目甘肃省重点研发计划联勤保障部队第九四〇医院血液病医学研究中心项目

21JR7RA01522YF7FA1062021yxky078

2024

中国病理生理杂志
中国病理生理学会

中国病理生理杂志

CSTPCD北大核心
影响因子:1.065
ISSN:1000-4718
年,卷(期):2024.40(8)
  • 3